Results 251 to 260 of about 8,209,000 (311)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study. [PDF]

open access: yesEur J Neurol
Høgset A   +6 more
europepmc   +1 more source

Generalized Difference-in-Differences

Epidemiology, 2022
Difference-in-differences (DID) analyses are used in a variety of research areas as a strategy for estimating the causal effect of a policy, program, intervention, or environmental hazard (hereafter, treatment). The approach offers a strategy for estimating the causal effect of a treatment using observational (i.e., nonrandomized) data in which ...
David B. Richardson   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy